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Introduction
Life expectancy in the United Kingdom has increased over time 
and more people are living longer [1]. Older people are at risk of social 
isolation, which is associated with higher rates of depression and 
unmet health care needs [2,3]. Zaninotto et al. determined that quality 
of life was higher in older people who had an absence of depression, 
absence of limiting illnesses, were in the richest quintile of wealth, were 
in employment, were cohabiting and were in the 80th percentile for a 
positive social network [4]. A review of health promotion strategies 
to prevent social isolation in older people found key determinants 
to consider when addressing social isolation were income and social 
status, personal health practices and coping skills and social support 
networks [5]. As well as affecting quality of life negatively, social 
isolation in older people is also believed to influence cognitive decline 
[6]. Alongside social engagement, participating in cognitive and 
physical activities may contribute to dementia prevention and risk 
reduction, thus there is a need to identify ways to promote and increase 
cognitive and physical activity in older people within a context of social 
participation [7]. A recent review of interventions aiming to increase 
physical activity in older people concluded that individually tailored 
interventions with defined personal goals may be more effective, 
however the review did not establish the evidence base for the cost-
effectiveness of physical activity interventions [8]. This paper describes 
the cost of setting up and delivering the Agewell community-based 
goal-setting intervention to increase activity in older people, along 
with cost-effectiveness findings. Effectiveness findings are published in 
Clare et al. [9].
Method
Study design
Full details of the Agewell study protocol are published as Clare et 
al. [10]. Agewell was a pilot randomised trial aiming to assess the effect 
of three different types of interview on subsequent behaviour change. 
The three arms of the pilot trial were a control condition (IC), a goal-
setting condition (GS) and a goal-setting with mentoring condition 
(GM). Assessments were carried out by blinded researchers at baseline 
and twelve months. Randomisation was conducted by the North Wales 
Organisation for Randomised Trials in Health (NWORTH) using a 
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Abstract
Background: Participation in cognitive and physical activities may help to maintain health and wellbeing in older 
people. The Agewell study explored the feasibility of increasing cognitive and physical activity in older people through a 
goal-setting approach. This paper describes the findings of the cost-effectiveness analysis. 
Method: Individuals over the age of 50 and attending an Agewell centre in North Wales were randomised to one of 
three conditions: control (IC), goal-setting (GS), or goal-setting with mentoring (GM). We undertook a cost-effectiveness 
analysis comparing GS vs. IC, GM vs. IC and GM vs. GS. The primary outcome measure for this analysis was the QALY, 
calculated using the EQ-5D. Participants’ health and social care contacts were recorded and costed using national unit 
costs. 
Results: Seventy participants were followed-up at 12 months. Intervention set up and delivery costs were £252 per 
participant in the GS arm and £269 per participant in the GM arm. Mean health and social care costs over 12 months 
were £1,240 (s.d. £3,496) per participant in the IC arm, £1,259 (s.d. £3,826) per participant in the GS arm and £1,164 
(s.d. £2,312) per participant in the GM arm. At a willingness to pay threshold of £20,000 per QALY there was a 65% 
probability that GS was cost-effective compared to IC (ICER of £1,070). However, there was only a 41% probability that 
GM was cost-effective compared to IC (ICER of £2,830) at a threshold of £20,000 per QALY. 
Conclusion: Setting up and running the community based intervention was feasible. Due to the small sample size 
it is not possible to draw a firm conclusion about cost-effectiveness; however, our preliminary results suggest that goal-
setting is likely to be cost-effective compared to the control condition of no goal-setting, the addition of mentoring was 
effective but not cost-effective.
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Economic evaluation
We undertook a cost-effectiveness analysis comparing GS vs IC, 
GM vs IC and GM vs GS. A public sector, multi-agency perspective was 
adopted for the economic evaluation. Cost-effectiveness analysis was 
conducted in line with MRC guidelines for the evaluation of complex 
interventions [16], and with our standard operating procedure for 
economic evaluations alongside randomised controlled trials [17]. The 
base case analysis was an intention-to-treat cost-utility analysis using 
the QALY. Non-parametric bootstrapping with 1000 replications [18] 
was used to address the uncertainty associated with point estimates of 
cost effectiveness ratios. To explore whether the results were robust 
to our assumptions, a sensitivity analysis was conducted to test the 
potential effect of the goal-setting interviews and mentoring being 
delivered by an ACGM staff member on an annual salary of £12,150.
Results
Seventy-five participants were randomised into the three 
conditions. At the 12 month follow-up, 70 participants completed 
measures for both the clinical-effectiveness and cost-effectiveness 
analysis (IC n=27, GS n=21, GM n=22), a retention rate of 93%.
Baseline data
Normality tests on baseline data indicated that the EQ-5D and 
cost data were not normally distributed, so the non-parametric 
Kruskal-Wallis test was used to test for significant differences between 
conditions. No significant differences existed at baseline (p=0.193 for 
costs, p=0.905 for EQ-5D;), so follow-up data used in the economic 
analysis were not adjusted for baseline values (Table 1). 
Mean EQ-5D index scores at baseline were between 0.862 and 
0.899. The UK population norm for this age group is 0.78 (s.d. 0.26) 
[19], indicating that Agewell participants had comparable health to the 
general population. 
Health and social care use over the study period
Table 2 shows health and social care contacts occurring between 
baseline and 12 month follow-up for the 70 participants who were 
assessed at both time-points. The mean cost per participant for health 
and social care contacts was £1,240.23 (s.d. £3,495.88) in the control 
condition, £1,258.66 (s.d. £3,825.71) in the goal-setting condition and 
£1,163.89 (s.d. £2,312.49) in the goal-setting with mentoring condition. 
The difference in costs between conditions was not significant (p=0.806) 
(Table 2). 
Other activities
Data on activities undertaken by participants outside of the Agewell 
centre during the study period were collected. This service use was 
low; 2 participants were enrolled on the local authority funded patient 
referral physical activity scheme and 1 participant was undertaking an 
unspecified local authority funded activity. These activities were not 
included in the cost analysis.
Intervention costs
Table 3 summarises the cost of setting up and running the Agewell 
centre and setting up and delivering the intervention. The costs of 
setting up the Agewell centre were annuitized over 3 years and included 
an ACGM development officer employed at 50% FTE, equipment costs, 
volunteer training, administration, promotion and recruitment costs. 
Based on attendance figures from the study period we estimated that 
up to 600 people would attend the centre during a 3 year time frame; 
dynamic adaptive computer algorithm. Randomisation was stratified 
by gender and married couples were randomised together to the same 
study arm to avoid cross-contamination. The AgeWell study was 
approved by the School of Psychology Research Ethics Committee at 
Bangor University. 
Study population
Individuals aged 50 years and over living in Nefyn, Gwynedd 
(North Wales) and attending the Nefyn Agewell Centre were invited 
to participate. No exclusion criteria were placed on individuals. 
Individuals attending the centre who did not wish to participate in the 
study were able to attend the centre as usual. 
Setting
The intervention was conducted in partnership with Age Cymru 
Gwynedd a Môn (ACGM). ACGM runs the Agewell Centre in Nefyn, 
Gwynedd, which was set up as part of the research project. The Agewell 
Centre is based in the village community centre and led by an AGCM 
co-ordinator, supported by a volunteer management group of centre 
attendees. The centre is open three days a week to provide social contact 
and a range of meaningful and enjoyable activities for over 50s. The 
program included a range of classes: exercise, computer, history and 
cookery. A range of other activities were also available inducing arts 
and crafts, bowling, Nordic walking, theatre trips, and photography.
Intervention
Participants randomised to the IC arm received an interview 
consisting of a general discussion about the centre facilities. Participants 
randomised to the GS arm received a structured goal-setting interview. 
Participants randomised to the GM arm received a structured goal-
setting interview supplemented by five mentoring telephone calls over 
the course of the one-year follow-up period.
Outcome measures for cost-effectiveness analysis 
A comprehensive list of outcome measures used in the Agewell 
study is available in the published protocol [10]. The primary outcome 
measure for the cost-effectiveness analysis was the quality-adjusted life 
year (QALY), calculated using the EQ-5D. The EQ-5D is a generic, 
preference based instrument for measuring health-related quality of 
life [11]. A scoring algorithm was used to convert responses into an 
index value of between -0.59 and 1, with 1 representing best possible 
health- related quality of life [12]. 
Measurement of intervention costs
The intervention was conducted at the Agewell centre, with 
centre set-up costs annuitized over 3 years. Staff time developing the 
intervention was classed as a set-up cost, and annuitized over 3 years. 
Staff time delivering the initial interviews in all three conditions, and 
conducting on-going mentoring phone calls in the goal-setting with 
mentoring condition, was costed. It was not necessary to discount 
intervention costs as the follow-up period was one year.
Measurement of health and social care costs
An adapted Client Service Receipt Inventory (CSRI) [13] was used 
to record participants’ contacts with primary and secondary health and 
social care services. National unit costs for the price year 2011-2012 
were assigned to services accessed, to calculate a mean total cost per 
participant [14,15]. Service use costs were not discounted as the follow-
up period was one year.
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IC (n=27)
Mean (s.d.)
GS (n=24)
Mean (s.d.)
GM (n=24)
Mean (s.d.)
Gender: Female (n, %) 23 (85.2%) 23 (95.8%) 19 (79.2%)
Age 70.22 (7.77) 67.50 (7.66) 66.67 (8.19)
Years of education 12.70 (2.91) 13.79 (3.18) 13.58 (2.68)
Living situation: living with others 15 (55.6%) 16 (66.7%) 18 (75.0%)
Social capital: good 8 (29.6%) 9 (37.5%) 8 (33.3%)
Social capital: poor 19 (70.4%) 15 (62.5%) 16 (66.7%)
Material deprivation: none 10 (37.0%) 7 (29.2%) 2 (8.3%)
Material deprivation: moderate 12 (44.4%) 13 (54.2%) 15 (62.5%)
Material deprivation: high 5 (18.5%) 4 (16.7%) 7 (29.2%)
EQ-5D index value 0.899 (0.141) 0.891 (0.133) 0.862 (0.227)
Subjective health: poor/ very poor 0 0 2 (8.3%)
Subjective health: not too good 4 (14.8%) 3 (12.5%) 0
Subjective health: good/ very good 23 (85.2%) 21 (87.5%) 22 (91.7%)
Health and social care contact cost for the 3 months before 
baseline £255.84 (£374.78) £169.96 (£250.47) £370.96 (£1,406.69)
Note: IC: Control, GS: Goal-Setting, GM: Goal-Setting With Mentoring.
Table 1: Baseline characteristics for the full sample.
Control (n=27) Goal-setting (n=21) Goal-setting with mentoring (n=22)
N (%)
Total 
contacts
Total cost
Mean cost per 
participant (SD)
N (%)
Total 
contacts
Total cost
Mean cost per 
participant (SD)
N (%)
Total 
contacts
Total cost
Mean cost per 
participant (SD)
General 
practitioner
24 (88.9%) 108 £7,388 £273.63 (£355.30) 17 (81.0%) 63 £4,073 £193.95 (£132.61) 19 (86.4%) 48 £3,024 £137.45 (£107.61)
Practice nurse 25 (92.6%) 58 £812 £30.07 (£28.72) 19 (90.5%) 77 £1,078 £51.33 (£75.57) 15 (68.2%) 43 £602 £27.36 (£40.64)
District nurse 2 (7.4%) 4 £244 £9.04 (£35.61) 1 (4.8%) 4 £280 £13.33 (£61.10) 3 (13.6%) 9 £618 £28.09 (£104.88)
Counsellor 0 0 0 0 1 (4.8%) 1 £60 £2.86 (£13.09) 0 0 0 0
Physiotherapist 6 (22.2%) 47 £1,551 £57.44 (£150.28) 4 (19.0%) 24 £792 £37.71 (£84.32) 5 (22.7%) 60 £1,980 £90.00 (£243.18)
Occupational 
health therapist
0 0 0 0 0 0 0 0 1 (4.5%) 1 £33 £1.50 (£7.04)
Chiropodist 7 (25.9%) 21 £630 £23.33 (£43.50) 4 (19.0%) 19 £570 £27.14 (£81.56) 2 (9.1%) 12 £360 £16.36 (£59.80)
Dietician 2 (7.4%) 8 £272 £10.07 (£46.02) 1 (4.8%) 8 £272 £12.95 (£59.36) 0 0 0 0
Dentist 1 (3.7%) 2 £50 £1.85 (£9.62) 3 (14.3%) 5 £125 £5.95 (£15.62) 1 (4.5%) 1 £25 £1.14 (£5.33)
Optician 1 (3.7%) 1 £21 £0.78 (£4.04) 0 0 0 0 3 (13.6%) 3 £63 £2.86 (£7.38)
Alternative 
therapist
2 (7.4%) 3 £51 £1.89 (£7.20) 0 0 0 0 1 (4.5%) 8 £136 £6.18 (£29.00)
Gynaecology 
nurse
0 0 0 0 1 (4.8%) 3 £243 £11.57 (£53.03) 0 0 0 0
Total community 
service use
- 252 £11,019 £408.11 (£417.60) - 204 £7,493 £356.81 (£357.75) - 185 £6,841 £310.95 (£372.37)
Outpatient service 14 (51.9%) 48 £5,088 £188.44 (£279.42) 10 (47.6%) 20 £2,120 £100.95 (£131.87) 12 (54.5%) 17 £1,802 £81.91 (£103.09)
Inpatient nights 3 (11.1%) 28 £17,379
£643.67 
(£3,032.70)
1 (4.8%) 21 £16,728
£796.56 
(£3,650.30)
4 (18.2%) 14 £16,872
£766.89 
(£2,024.62)
Accident and 
Emergency
0 0 0 0 1 (4.8%) 1 £91 £4.33 (£19.86) 1 (4.5%) 1 £91 £4.14 (£19.40)
Total hospital use - - £22,467
£832.12 
(£3,159.32)
- - £18,939
£901.85 
(£3,725.00)
- - £18,765
£852.94 
(£2,093.18)
TOTAL - - £33,486
£1,240.23 
(£3,495.88)
- - £26,432
£1,258.66 
(£3,825.71)
- - £25,606
£1,163.89 
(£2,312.49)
Table 2: Health and social care contacts in the 12 months following baseline.
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thus we divided the total cost by 600 to estimate the cost per person. 
Centre running costs included staff costs, rent and administration costs 
e.g. utility bills. 
Developing the intervention took 65 hours. Training staff to deliver 
the interviews (both control and goal-setting) took 10 hours. In the 
intervention delivery, the baseline interview was conducted by a trained 
researcher. The average length of interviews for participants in the 
control condition was 60 minutes. The average length of interviews for 
participants in the intervention conditions (GS, GM) was 90 minutes. 
Participants in the GM condition received an average of 5 mentoring 
phone calls, lasting approximately 10 minutes per call (Table 3). 
Cost to participants
Centre attendees were asked for a financial contribution to cover 
the cost of hiring external facilitators, regardless of whether they were 
trial participants or not. Each attendee paid £2.50 per session for 
activities such as tai chi, line dancing, ballroom dancing, calligraphy, 
choir, pottery, exercise class and Nordic walking. The cost of healthy 
eating and arts classes was slightly lower at £2.00 per person. During 
the study period, trial participants paid a mean of £59.55 per person for 
session fees (s.d. £77.32, range £0-£272.50).
Cost-effectiveness analysis
The mean costs (including intervention costs) and QALYs accrued 
between baseline and 12 months for each trial arm are shown in Table 
4. In this pilot study a small incremental QALY gain was seen between 
GS and IC, and the incremental cost-effectiveness ratio (ICER) between 
conditions was £1,070 (Table 4). 
Figure 1 shows the cost-effectiveness planes for the GS and GM 
conditions compared to the control condition. The majority of plots in 
the GS cost-effectiveness plane fall in the East of the figure, suggesting 
that GS is more effective than the control condition. More plots fall in 
the West of the cost-effectiveness plane for GM compared to control 
(Figure 1).
Cost-effectiveness acceptability curves indicate the probability 
that an intervention is cost-effective at a range of willingness to pay 
thresholds. The cost-effectiveness acceptability curve in Figure 2 
indicates a 65% probability that GS was cost-effective compared to the 
control condition at the NICE threshold of £20,000 per QALY [20]. 
However, the cost-effectiveness acceptability curve for GM compared 
to control indicated only a 41% probability of being cost-effective 
compared to the control condition at a threshold of £20,000 per QALY. 
Comparing GM to GS, there was a 36% probability that GM was cost-
effective at a threshold of £20,000 per QALY (Figure 2).
Sensitivity analysis
In the base case analysis, the goal-setting interviews and 
mentoring calls were conducted by a researcher on an annual salary of 
approximately £33,000. We conducted a sensitivity analysis to explore 
the effect of the goal-setting interviews and mentoring being delivered 
by an ACGM staff member on an annual salary of approximately 
£12,000. In this scenario the cost per participant (including centre 
costs and intervention costs) was £228.94 in the control condition, 
£233.18 in the goal-setting condition and £240.25 in the goal-setting 
with mentoring condition (Table 5).
Discussion
The Agewell pilot study explored the feasibility of setting up and 
Total cost, 
annuitized over 
3 years
Cost per 
person
One-off centre set-up cost £11,600.14 £19.331
Annual cost of running the centre £38,122.44 £190.612
Intervention development and set-up cost £862.62 £11.503
60 minute control interview cost per person- IC arm - £20.32
90 minute goal-setting interview cost per person- 
GS arm
- £30.48
90 minute goal-setting interview and mentoring 
cost per person- GM arm
- £47.41
Total cost per participant, including centre and intervention costs
IC arm £241.77
GS arm £251.93
GM arm £268.86
IC: Control, GS: Goal-Setting, GM: Goal-Setting With Mentoring
1Based on up to 600 people attending over 3 years
2Based on up to 200 people attending per year
3Based on the 75 participants randomised in the study
Table 3: Costs of setting up and running the centre and intervention.
IC (n=27) GS (n=21) GM (n=22)
Mean (s.d.) cost £1,482.00 
(£3,495.88)
£1,510.59 
(£3,825.71)
£1,432.75 
(£2,312.49)
Mean (s.d.) QALY 0.8464 (0.1849) 0.8731 (0.1670) 0.8290 (0.2442)
GS v IC 
(95% CI)
GM v IC 
(95% CI)
GM v GS 
(95% CI) 
Incremental cost £28.58
(-£2,045.86 to 
£1,957.86)
-£49.25
(-£1,728.65 to 
£1,528.18)
-£77.83
(-£2,150.62 to 
£1,540.99 )
Incremental QALY 0.0267
(-0.078 to 0.127)
-0.0174
(-0.156 to 0.092)
-0.0441
(-0.163 to 0.077)
ICER £1,070 £2,830 £1,765
Probability of cost-
effectiveness at 
£20,000 per QALY
65% 41% 36%
Probability of cost-
effectiveness at 
£30,000 per QALY
68% 44% 33%
Note: GS: Goal-Setting, GM: Goal-Setting with Mentoring, IC: Control
Table 4: Incremental costs and QALYs between conditions at 12 months.
GS v IC 
(95% CI)
GM v IC 
(95% CI)
GM v GS 
(95% CI) 
Incremental cost £22.66
(-£2,072.96 to 
£2,365.28)
-£65.03
(-£1,792.80 to 
£1,404.68)
-£87.69
(-£2,275.11 to 
£1,492.09 )
Incremental QALY 0.0267
(-0.078 to 0.127)
-0.0174
(-0.156 to 0.092)
-0.0441
(-0.163 to 0.077)
ICER £849 £3,737 £1,988
Probability of cost-
effectiveness at 
£20,000 per QALY
65% 44% 32%
Probability of cost-
effectiveness at 
£20,000 per QALY
67% 43% 28%
Note: GS: Goal-Setting, GM: Goal-Setting with Mentoring, IC: Control
Table 5: Sensitivity analysis.
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Figure 1: Cost-effectiveness plane for the QALY with 1,000 bootstrapped 
ICER estimates; GS v IC on the left and GM v IC on the right.
 
Figure 2: Cost-effectiveness acceptability curves for GS vs. IC and GM vs. IC.
delivering a community based goal-setting intervention with the aim 
of promoting physical and cognitive activity in older people. The 
Agewell centre was set up and the target study size of 75 participants 
to be randomised was achieved, indicating that the study was feasible. 
Attendance at the centre was good, with participants attending a mean 
of 34 activity sessions over the year. Furthermore, at 12 month follow-
up 70 participants were assessed, which is a retention rate of 93%. The 
sample size for cost-effectiveness analysis is often smaller than the 
full clinical effectiveness sample due to fewer participants providing 
complete information on health and social care resource use. In this 
study, all 70 participants in the clinical effectiveness sample completed 
the resource use questionnaire and were used in the cost-effectiveness 
analysis. Health and social care costs did not differ significantly 
between the control and goal-setting conditions over 12 months, and 
the incremental cost between conditions was low meaning that the 
intervention is unlikely to have affected participants’ patterns of health 
and social care use in the short-term.
The partnership with Age Cymru Gwynedd a Môn (ACGM) 
and the involvement of the volunteer management group of centre 
attendees was key to the success of the study. The program of activities 
offered at the Agewell Centre was developed following consultation 
with centre attendees, encouraging engagement between participants 
and the centre. A co-ordinator was employed by the centre, and 
trained volunteers provided additional support. Attendance records 
for the centre indicate that up to 200 people could attend the centre 
annually. The annual cost of running the centre was estimated to be 
£38,122 in total or £191 per attendee (including non-trial attendees). 
In comparison to centre set-up and running costs, the delivery of 
the intervention was low cost as it only required the additional staff 
time involved in conducting the initial goal-setting interviews and 
subsequent mentoring calls. 
The findings from the clinical effectiveness analysis in Clare et 
al. [9] showed that participants in all three arms of the pilot study 
benefitted across a range of outcome measures; however a specific 
focus on identifying individual behaviour change goals in a goal-setting 
interview was required to achieve increased activity engagement 
and greater benefits in cognition, health, diet and fitness. This paper 
explored the cost-effectiveness of the intervention and found that goal-
setting is likely to be cost-effective compared to the control condition; 
however, while the addition of mentoring is likely to be effective, it is 
unlikely to be cost-effective. The goal-setting interviews were carried 
out by a researcher; however a sensitivity analysis was undertaken 
exploring the effect of the interviews being carried out by an ACGM 
staff member on a lower salary. The sensitivity analysis supported the 
base case analysis, in that goal-setting was likely to be cost-effective 
compared to the control condition.
Conclusion
The preliminary cost-effectiveness results indicate a high 
probability that the goal-setting intervention is cost-effective compared 
to the control condition at a threshold of £20,000-£30,000 per 
QALY gained. However, due to the small sample size and the QALY 
differences between groups not being statistically significant, it is not 
possible to conclusively state that the intervention was cost-effective 
compared to control, and a larger scale study is required. Community-
based interventions aimed at increasing physical, cognitive and social 
activity in older people may have a beneficial effect on health, so low-
cost interventions such as the Agewell pilot study have an important 
role to play in keeping people active in the community.
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